BIB icon

ProShares Ultra NASDAQ Biotechnology

27 hedge funds and large institutions have $16.2M invested in ProShares Ultra NASDAQ Biotechnology in 2018 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 4 increasing their positions, 9 reducing their positions, and 16 closing their positions.

New
Increased
Maintained
Reduced
Closed

more call options, than puts

Call options by funds: $ | Put options by funds: $

less ownership

Funds ownership:

less funds holding

Funds holding:

less capital invested

Capital invested by funds: $ → $

56% less repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 9

81% less first-time investments, than exits

New positions opened: 3 | Existing positions closed: 16

Holders
27
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$6.66M
Puts
$4.96M
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
1
$5.17M
2
$3.21M
3
$1.95M
4
$1.52M
5
$1.11M
6
$691K
7
$669K
8
$631K
9
$381K
10
$376K
11
$73K
12
$69K
13
$62K
14
$53K
15
$42K
16
$32K
17
$27K
18
$19K
19
$16K
20
$13K
21
$8K
22
$8K
23
$7K
24
$7K
25
$6K